Anti-CD38 mAb Market to Accelerate Substantially During the Study Period (2020-2034) Owing to a Strong Uptake of DARZALEX in Multiple Myeloma and Expected Entry of anti-CD38 mAbs in Autoimmune Diseases | DelveInsight
The anti-CD38 mAb market is projected to experience substantial growth in the coming years owing to strong uptake of DARZALEX…
